Search research articles
Contact Us
Filters
Showing results (301-310 of 305) with videos related to
Page
of 31
Sort By:
You have reached the last page of results.
This site can display upto 305 results.
Blood
|
March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
Nicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Blood Advances
|
December 24, 2019
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso, et al.
The Lancet. Haematology
|
October 14, 2019
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Dietrich Wilhelm Beelen, Rudolf Trenschel, Matthias Stelljes, et al.
The Lancet. Haematology
|
August 18, 2020
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
American Journal of Hematology
|
November 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, et al.
Page
of 31
Search research articles
Search
Showing results (301-310 of 305) with videos related to
Sort By:
Page
of 31
You have reached the last page of results.
This site can display upto 305 results.
Blood
|
March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
Nicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Blood Advances
|
December 24, 2019
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP
Michele Baccarani, Elisabetta Abruzzese, Vincenzo Accurso, et al.
The Lancet. Haematology
|
October 14, 2019
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Dietrich Wilhelm Beelen, Rudolf Trenschel, Matthias Stelljes, et al.
The Lancet. Haematology
|
August 18, 2020
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
American Journal of Hematology
|
November 26, 2025
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, et al.
Page
of 31